Zhang Shuyan, Chen Huiting, Wang Jinke
State Key Laboratory of Bioelectronics, Southeast University, Nanjing 210096, China.
Mol Ther Methods Clin Dev. 2019 Feb 19;13:310-320. doi: 10.1016/j.omtm.2019.02.004. eCollection 2019 Jun 14.
TALE has always had potential as a gene-editing and regulatory tool. However, with the advent of CRISPR/Cas9, an easier to use tool with the same function, TALE has recently been abandoned because of the time-consuming and low-efficiency process required for its construction. The off-target activity of CRISPR/Cas9 has been a challenge to its application. By contrast, TALE has been applied for gene editing and therapy because of its high targeting capability. To overcome the key limitation of the TALE technique, we developed a high-efficiency method for constructing custom TALEs. We created 62 new monomers and developed a new pipeline that enabled assembly of custom TALEs in just 1 day. We verified the new method by assembling nine TALEs targeting the promoters of two transcription factor genes: HNF4α and E47. The expression of the two endogenous genes in two cancer cells, HepG2 and PANC1, was activated by the constructed TALEs, which promoted differentiation of the two cancer cells. Using the new method, custom TALEs can be generated as easily and rapidly as CRISPR, thus promoting the wide application of TALE-based techniques.
转录激活样效应因子(TALE)一直具有作为基因编辑和调控工具的潜力。然而,随着CRISPR/Cas9这一具有相同功能但更易于使用的工具的出现,由于构建TALE耗时且效率低下,它最近已被弃用。CRISPR/Cas9的脱靶活性一直是其应用面临的一个挑战。相比之下,TALE因其高靶向能力已被应用于基因编辑和治疗。为了克服TALE技术的关键局限性,我们开发了一种构建定制TALE的高效方法。我们创建了62种新的单体,并开发了一种新流程,可在短短1天内实现定制TALE的组装。我们通过组装针对两个转录因子基因HNF4α和E47启动子的9个TALE验证了新方法。构建的TALE激活了两种癌细胞HepG2和PANC1中两个内源基因的表达,促进了这两种癌细胞的分化。使用新方法,可以像CRISPR一样轻松快速地生成定制TALE,从而促进基于TALE技术的广泛应用。